Safety, tolerability and pharmacokinetics of phenoprolamine hydrochloride floating sustained-release tablets in healthy Chinese subjects

International Journal of Pharmaceutics

Volumn 377, Issue 1-2, 2009, Pages 99-104

  Zhao, Libo ^a   Yang, Xiaoyan ^a   Xu, Rong ^a   Wu, Jianhong ^a   Gu, Shifen ^a   Zhang, Li ^a   Gong, Peili ^a   Chen, Hui ^a   Zeng, Fandian ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Healthy Chinese subjects; Pharmacokinetics; Phenoprolamine hydrochloride floating sustained tablets; Safety; Tolerability

Indexed keywords

ANTIHYPERTENSIVE AGENT; PHENOPROLAMINE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CHINESE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOOD; FOOD DRUG INTERACTION; HUMAN; HUMAN EXPERIMENT; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; QT PROLONGATION; SIDE EFFECT; SINGLE DRUG DOSE; SUSTAINED DRUG RELEASE;

ADULT; ANTIHYPERTENSIVE AGENTS; ASIAN CONTINENTAL ANCESTRY GROUP; DELAYED-ACTION PREPARATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR STRUCTURE; PHENETHYLAMINES; TABLETS;

EID: 67649639651     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.05.010     Document Type: Article

References (19)

1. Berkow S.E., and Barnard N.D. Blood pressure regulation and vegetarian diets. Nutr. Rev. 63 (2005) 1-8
2. Carter B.L. Implementing the new guidelines for hypertension: JNC 7, ADA, WHO-ISH. J. Manag. Care Pharm. 10 (2004) S18-25
3. Chen C.M., Zhao W., Yang Z., Zhai Y., Wu Y., and Kong L. The role of dietary factors in chronic disease control in China. Obes. Rev. 9 Suppl. 1 (2008) 100-103
4. Ding L., Zhang Z.X., Ni P.Z., Wang G.J., and An D.K. Study on the phase I metabolites of phenoprolamine hydrochloride in rat bile by LC/DAD/MSD. Yao Xue Xue Bao 36 (2001) 205-209
5. Ding L., Zhang Z.X., Ni P.Z., Wang G.J., and An D.K. Study on the phase II metabolites of phenoprolamine hydrochloride in rat bile by LC/DAD/MSD. Yao Xue Xue Bao 36 (2001) 440-443
6. He Z., Huang L., Wu Y., Wang J., Wang H., and Guo L. DDPH: improving cognitive deficits beyond its alpha 1-adrenoceptor antagonism in chronic cerebral hypoperfused rats. Eur. J. Pharmacol. 588 (2008) 178-188
7. Heneghan C., Perera R., Mant D., and Glasziou P. Hypertension guideline recommendations in general practice: awareness, agreement, adoption, and adherence. Br. J. Gen. Pract. 57 (2007) 948-952
8. Hu X.D., and Qian J.Q. DDPH inhibited L-type calcium current and sodium current in single ventricular myocyte of guinea pig. Acta Pharmacol. Sin. 22 (2001) 415-419
9. Liu H., Ran C.Z., Xia L., and Ni P.Z. Synthesis and anti alpha-adrenoceptor activity in vitro of 4-((4-((2-substituted phenoxy)ethyl)-1-piperazinyl)methyl)-1,2-dihydro-quinoline-2-one compounds. Yao Xue Xue Bao 37 (2002) 181-185
10. Lu Z.Z., Zhang Y.Y., Xia L., and Han Q.D. Antagonistic characterization of 1-(2,6-dimethylphenoxyl)-2-(3,4-dimethylphenyl ethylamino) propane hydrochloride on alpha 1-adrenoceptor. Yao Xue Xue Bao 35 (2000) 739-742
11. Ni X.P., Qian J.Q., Hu C.J., Xia L., Ni P.Z., and Mo F.Z. Hypotensive effect of 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino) propane hydrochloride. Zhongguo Yao Li Xue Bao 9 (1988) 64-68
12. Qian J., Feng G., and Liang H. Action of DDPH in the interventional treatment of portal hypertension induced by liver cirrhosis in rabbits. J. Tongji Med. Univ. 18 (1998) 108-112
13. Qu L., Wang W.T., Guo L.J., Wang F., Lu Q., and Qian J.Q. Protective effects of 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino) propane hydrochloride (DDPH) on brain ischemia injury in rats. Yao Xue Xue Bao 38 (2003) 725-727
14. Stergiou G.S., and Salgami E.V. New European, American and International guidelines for hypertension management: agreement and disagreement. Expert Rev. Cardiovasc. Ther. 2 (2004) 359-368
15. Xiong Y.L., and Qian J.Q. Effects of 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino) propane hydrochloride on proliferation of vascular smooth muscle cells and PDGF-B, bFGF, c-sis, c-myc in spontaneously hypertensive rat. Yao Xue Xue Bao 32 (1997) 658-662
16. Xu X., Sun M., Zhi F., and Hu Y. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers. Int. J. Pharm. 310 (2006) 139-145
17. Yuan Y., Che D., and Xiong M. Effects of DDPH on proliferation and immunophenotypes of the pulmonary vascular pericytes. Zhonghua Jie He He Hu Xi Za Zhi 24 (2001) 101-104
18. Zhang Z.B., Wang C.B., Li W., and Qian J.Q. Effects of 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino) propane hydrochloride on heart function, lactate dehydrogenase and its isoenzymes in rats with cardiac hypertrophy. Zhongguo Yao Li Xue Bao 19 (1998) 54-57
19. Zhong N., Fang Q.Z., Zhang Y., Xia J.S., Qian J.Q., and Zhou Z.N. Inhibitory effects of DDPH on two components of delayed rectifier potassium current in guinea pig ventricular cells. Acta Pharmacol. Sin. 23 (2002) 601-608